Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study

BACKGROUND: Early prediction of treatment response to neoadjuvant chemotherapy (NACT) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer can facilitate timely adjustment of treatment regimens. We aimed to develop and validate a Siamese multi-task network (SMTN) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Wang, Ying, Wang, Yuxiang, Xie, Yu, Cui, Yanfen, Feng, Senwen, Yao, Mengxia, Qiu, Bingjiang, Shen, Wenqian, Chen, Dong, Du, Guoqing, Chen, Xin, Liu, Zaiyi, Li, Zhenhui, Yang, Xiaotang, Liang, Changhong, Wu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343415/
https://www.ncbi.nlm.nih.gov/pubmed/35928032
http://dx.doi.org/10.1016/j.eclinm.2022.101562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343415/
https://www.ncbi.nlm.nih.gov/pubmed/35928032
http://dx.doi.org/10.1016/j.eclinm.2022.101562

Ejemplares similares